TELA Bio, Inc.
1 Great Valley Parkway, Suite 24
Malvern, Pennsylvania 19355
 

 

December 28, 2020

 

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Manufacturing

100 F Street NE

Washington, D.C. 20549

 

 

Re:		TELA Bio, Inc.
		Registration Statement on Form S-3
		SEC File No. 333-251505
		Filed December 18, 2020

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, TELA Bio, Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-251505) (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:00 PM, eastern time, on December 29, 2020, or as soon thereafter as is practicable.

 

Please feel free to direct any questions or comments concerning this request to Rachael Bushey, Esq. of Troutman Pepper Hamilton Sanders LLP at (215) 981-4331.

 

 

	TELA BIO, Inc.
	By:	/s/ Antony Koblish
		Name: Antony Koblish
		Title: President and Chief Executive Officer

 

 

Cc: Rachael Bushey, Troutman Pepper Hamilton Sanders LLP